These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7519887

  • 1. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD.
    Clin Infect Dis; 1994 Jan; 18(1):83-90. PubMed ID: 7519887
    [Abstract] [Full Text] [Related]

  • 2. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Cortés E, Ribera E, Cucurull E, de Otero J, Ocaña I, Pahissa A.
    Med Clin (Barc); 1995 Apr 22; 104(15):578-80. PubMed ID: 7769868
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
    Berhe N, Abraham Y, Hailu A, Ali A, Mengistu G, Tsige K, Abebe Y.
    East Afr Med J; 2001 Nov 22; 78(11):608-10. PubMed ID: 12219968
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N, Kara C, Bakirtaç A, Teziç T.
    Pediatr Infect Dis J; 2001 Apr 22; 20(4):455-7. PubMed ID: 11332679
    [Abstract] [Full Text] [Related]

  • 5. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC, Romero GA, Merchan-Hamann E, Magalhães AV, Macedo Vde O.
    Rev Soc Bras Med Trop; 1999 Apr 22; 32(4):383-7. PubMed ID: 10495667
    [Abstract] [Full Text] [Related]

  • 6. Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
    Veiga JP, Wolff ER, Sampaio RN, Marsden PD.
    Lancet; 1983 Sep 03; 2(8349):569. PubMed ID: 6136717
    [No Abstract] [Full Text] [Related]

  • 7. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H, Rojas E, Garcia L, Desjeux P, Dujardin JC, Boelaert M, Chappuis F.
    Ann Trop Med Parasitol; 2006 Oct 03; 100(7):591-600. PubMed ID: 16989685
    [Abstract] [Full Text] [Related]

  • 8. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
    Veiga JP, Rosa TT, Kimachi T, Wolff ER, Sampaio RN, Gagliardi AR, Junqueira Júnior LF, Costa JM, Marsden PD.
    Rev Inst Med Trop Sao Paulo; 1985 Oct 03; 27(6):298-302. PubMed ID: 3014634
    [No Abstract] [Full Text] [Related]

  • 9. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M, Bitnun A, Shaked P, Waldman E, Zilberstein D.
    Antimicrob Agents Chemother; 1999 Feb 03; 43(2):278-82. PubMed ID: 9925518
    [Abstract] [Full Text] [Related]

  • 10. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
    Delgado J, Macías J, Pineda JA, Corzo JE, González-Moreno MP, de la Rosa R, Sánchez-Quijano A, Leal M, Lissen E.
    Am J Trop Med Hyg; 1999 Nov 03; 61(5):766-9. PubMed ID: 10586909
    [Abstract] [Full Text] [Related]

  • 11. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C.
    Clin Infect Dis; 1993 May 03; 16(5):730-1. PubMed ID: 8507769
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
    Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N.
    Acta Derm Venereol; 2024 Apr 29; 104():adv35089. PubMed ID: 38682801
    [Abstract] [Full Text] [Related]

  • 13. Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
    Berhe N, Ali A, Hailu A, Yeneneh H.
    Acta Trop; 1994 Jun 29; 57(1):83-90. PubMed ID: 7942358
    [Abstract] [Full Text] [Related]

  • 14. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
    Marsden PD, Sampaio RN, Carvalho EM, Veiga JP, Costa JL, Llanos-Cuentas EA.
    Am J Trop Med Hyg; 1985 Jul 29; 34(4):710-3. PubMed ID: 2992304
    [Abstract] [Full Text] [Related]

  • 15. Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis.
    Lambertucci JR, França BM, Queiroz Ede M.
    Rev Soc Bras Med Trop; 2004 Jul 29; 37(1):74-5. PubMed ID: 15042193
    [No Abstract] [Full Text] [Related]

  • 16. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
    Shahian M, Alborzi A.
    Med Sci Monit; 2009 Jun 29; 15(6):CR290-3. PubMed ID: 19478699
    [Abstract] [Full Text] [Related]

  • 17. Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
    Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, Balasegaram M, Hailu A.
    Trans R Soc Trop Med Hyg; 2010 Nov 29; 104(11):706-12. PubMed ID: 20870258
    [Abstract] [Full Text] [Related]

  • 18. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
    Amato VS, de Oliveira LS, Silva AC, Machado FR, Amato JG, Nicodemo AC, Amato Neto V.
    Rev Soc Bras Med Trop; 1998 Nov 29; 31(2):221-4. PubMed ID: 9608241
    [Abstract] [Full Text] [Related]

  • 19. The effect of pentavalent antimonial compounds used in the treatment of cutaneous leishmaniasis on hemogram and biochemical parameters.
    An I, Harman M, Esen M, Çelik H.
    Cutan Ocul Toxicol; 2019 Sep 29; 38(3):294-297. PubMed ID: 31039622
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil.
    Marsden PD.
    Rev Inst Med Trop Sao Paulo; 1993 Sep 29; 35(6):589. PubMed ID: 7997767
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.